Your browser doesn't support javascript.
loading
Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study.
Mochizuki, Seibu; Dahlöf, Björn; Shimizu, Mitsuyuki; Ikewaki, Katsunori; Yoshikawa, Makoto; Taniguchi, Ikuo; Ohta, Makoto; Yamada, Taku; Ogawa, Kazuhiko; Kanae, Kiyoshi; Kawai, Makoto; Seki, Shingo; Okazaki, Fumiko; Taniguchi, Masayuki; Yoshida, Satoru; Tajima, Naoko.
Afiliación
  • Mochizuki S; Division of Cardiology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan. Electronic address: m_seibu@jikei.ac.jp.
  • Dahlöf B; Institute of Medicine, Department of Emergency and Cardiovascular Medicine, Sahlgrenska University Hospital/Östra, Göteborg, Sweden.
  • Shimizu M; Division of Cardiology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
  • Ikewaki K; Division of Cardiology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
  • Yoshikawa M; Division of Cardiology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
  • Taniguchi I; Division of Cardiology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
  • Ohta M; Division of Cardiology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
  • Yamada T; Division of Cardiology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
  • Ogawa K; Division of Cardiology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
  • Kanae K; Division of Cardiology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
  • Kawai M; Division of Cardiology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
  • Seki S; Division of Cardiology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
  • Okazaki F; Division of Cardiology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
  • Taniguchi M; Division of Cardiology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
  • Yoshida S; Division of Cardiology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
  • Tajima N; Division of Diabetes, Metabolism, and Endocrinology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
Lancet ; 369(9571): 1431-1439, 2007 Apr 28.
Article en En | MEDLINE | ID: mdl-17467513
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tetrazoles / Valina / Presión Sanguínea / Enfermedad Coronaria / Determinación de Punto Final / Antagonistas de Receptores de Angiotensina / Insuficiencia Cardíaca / Hipertensión / Antihipertensivos Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Lancet Año: 2007 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tetrazoles / Valina / Presión Sanguínea / Enfermedad Coronaria / Determinación de Punto Final / Antagonistas de Receptores de Angiotensina / Insuficiencia Cardíaca / Hipertensión / Antihipertensivos Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Lancet Año: 2007 Tipo del documento: Article Pais de publicación: Reino Unido